Table 1.
Baseline characteristics of all patients with COVID-19 and hematologic malignancies
| n (%) | |
|---|---|
| Age, y | |
| <19 | 20 (8) |
| 19-39 | 31 (12) |
| 40-69 | 105 (42) |
| >70 | 89 (36) |
| No response | 5 (2) |
| Sex | |
| Male | 143 (57) |
| Female | 102 (41) |
| No response | 5 (2) |
| Race/ethnicity | |
| Asian | 29 (12) |
| Black/African American | 35 (14) |
| White | 105(42) |
| Other/unknown/no response | 81 (32) |
| Comorbidity* | |
| Diabetes | 46 (33) |
| Hypertension | 75 (54) |
| Heart disease | 35 (25) |
| Lung disease | 25 (18) |
| Kidney disease | 29 (21) |
| Other | 43 (33) |
| Smoking status | |
| Current | 10 (4) |
| Former | 54 (22) |
| Never | 109 (44) |
| Unknown/no response | 77 (31) |
| Hematologic malignancy | |
| Acute leukemia | 82 (33) |
| Chronic lymphocytic leukemia | 29 (12) |
| Hodgkin lymphoma | 11 (4) |
| Non-Hodgkin lymphoma | 68 (27) |
| Myeloproliferative neoplasm | 24 (10) |
| Myeloma or amyloidosis | 40 (16) |
| Estimated pre–COVID-19 prognosis, mo | |
| <3 | 10 (4) |
| 3-6 | 22 (9) |
| 6-12 | 15 (6) |
| >12 | 154 (62) |
| No response | 49 (20) |
*
Comorbidities: heart disease included congestive heart failure, coronary artery disease, and other chronic heart diseases; lung disease included chronic obstructive pulmonary disease/emphysema and other chronic lung diseases; kidney disease included chronic renal insufficiency.